Assignee
VYNE THERAPEUTICS INC
US·3 granted patents·6 pending applications·5 citations·filing 2018–2023
Top patents by PatentIndex Score
9 records- 0192US11103454B2Wax foamable vehicle and pharmaceutical compositions thereofVYNE THERAPEUTICS INC·Filed 2019·Granted Aug 31, 2021·4 cites·36 claims
- 0284US11324691B2Compositions and methods for treating rosacea and acneVYNE THERAPEUTICS INC·Filed 2020·Granted May 10, 2022·1 cites·26 claims
- 0369US11026920B2Use of NK-1 receptor antagonist serlopitant in pruritusVYNE THERAPEUTICS INC·Filed 2020·Granted Jun 8, 2021·0 cites·20 claims
- 0459US2023320984A1Tofacitinib-containing anhydrous elastomer-based gel formulationsVYNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0554US2025339409A1Uses of pan bet inhibitorsVYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0651US2024325393A1Tofacitinib-containing anhydrous elastomer-based gel formulationsVYNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0749US2023037905A1Topical composition comprising tofacitinib and fingolimodVYNE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0844US2023123488A1Stable topical tetracycline compositionsVYNE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0939US2021169848A1Use of neurokinin-1 antagonists to treat pruritusVYNE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →